Home › Companies › Theravance Biopharma, Inc.
How asset managers voted at Theravance Biopharma, Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.
| Season | Filed as | Ballot items | Asset managers |
|---|---|---|---|
| 2025-2026 | Theravance Biopharma, Inc. | 8 | 213 |
| 2024-2025 | Theravance Biopharma, Inc. | 6 | 131 |
| 2023-2024 | THERAVANCE BIOPHARMA INC. | 5 | 146 |
Earlier seasons list this company under the name THERAVANCE BIOPHARMA INC., as its holders filed it.
Explore Theravance Biopharma, Inc. in the interactive database
The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. This page is rebuilt weekly; built October 15, 2026.